Home » FDA Approval of Easypod: New Electronic Growth Hormone Injection Device
FDA Approval of Easypod: New Electronic Growth Hormone Injection Device
Merck Serono, a division of Merck KGaA, announced that its U.S. affiliate, EMD Serono, Inc. received U.S. Food and Drug Administration (FDA) approval of easypod, an innovative delivery system for the administration of Saizen [somatropin (rDNA origin) for injection], a treatment for growth hormone deficiency.
Merck
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May